Title: IRESSA (gefitinib) | Non Small Cell Lung Cancer Treatment
Description: Official site of IRESSA (gefitinib), indicated in Europe for the treatment of adults with locally advanced or metastatic NSCLC with activating mutations of EGFR-TK across all lines of therapy.